Journal profile · Endocrinology & Metabolism
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
ISSN 0021-972X · eISSN 1945-7197 · Oxford University Press · UNITED STATES · Monthly · Founded 1952
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 5.33; hybrid open access; APC about USD 3,750; median 91 days to acceptance (108 articles, last 24 months); community-reported acceptance: fairly hard; 740 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM is published by Oxford University Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Growth Hormone and Insulin-like Growth Factors, Thyroid Disorders and Treatments and Pituitary Gland Disorders and Treatments, together about 26.4% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Clinical Endocrinology & Metabolism is the world’s leading peer-reviewed journal for research related to clinical endocrinology, diabetes, and metabolism from investigators across the globe. JCEM will consider in scope: The full spectrum of translational research from discovery science to experimental medicine and from critical evaluation of new treatments to patient-population-related outcomes Novel developments that enhance understanding of the pathophysiology, diagnosis, and treatment of endocrine and metabolic disorders Original research that reveals insight into the metabolic-endocrine basis for, or treatment of, other related conditions including cardiovascular disease, cancer, and aging Innovations at the interface of technology and endocrinology that improve understanding, treatment of disease, and patient care, for example genomics and cell-based therapies, imaging, and digital/data-driven/artificial intelligence-enabled approaches JCEM will not consider: Research that falls outside of the journal’s scope of “clinical endocrinology, diabetes, and metabolism”, as outlined above Research focused exclusively on animal or other pre-clinical data without direct clinical translation Isolated association studies that fail to validate or refute experimental data included within the same article Mendelian Randomization studies that lack clear mechanistic basis Research based primarily on self-reported patient data Clinical case reports, which should be submitted to our sister journal JCEM Case Reports
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Paul M. StewartPublisher website
Editorial board by country: 10 in mainland China (about 9%); most named United States 31, Mainland China 10, United Kingdom 9, Japan 6, Germany 5 (113 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Growth Hormone and Insulin-like Growth FactorsMedicine11.2%
- Thyroid Disorders and TreatmentsMedicine8.4%
- Pituitary Gland Disorders and TreatmentsMedicine6.9%
- Hormonal and reproductive studiesMedicine6.3%
- Hormonal Regulation and HypertensionMedicine5.7%
- Adrenal Hormones and DisordersMedicine5.2%
- Thyroid Cancer Diagnosis and TreatmentMedicine4.8%
- Ovarian function and disordersMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.33LetPub ·
- Impact factor (publisher) 2025
- 11Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.9Publisher website ·
- CiteScore 2026-06
- 11LetPub ·
- CiteScore (publisher) 2025
- 11Publisher website ·
- SJR 2026-06
- 2.15LetPub ·
- SNIP 2026-06
- 2.12LetPub ·
- h-index
- 328LetPub ·
- h-index
- 491OpenAlex ·
- i10-index
- 40,372OpenAlex ·
- 2-year mean citedness
- 5.85OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 37.43%LetPub ·
Volume
- Articles per year
- 553LetPub ·
- Downloads per year (publisher) 2025
- 5,891,920Publisher website ·
Articles by year OpenAlex count · 52,491 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 397 | 234 | 312 |
| 2025 | 740 | 424 | 3,241 |
| 2024 | 890 | 626 | 8,300 |
| 2023 | 763 | 543 | 12,490 |
| 2022 | 762 | 659 | 15,605 |
| 2021 | 961 | 863 | 24,652 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
91 daysMedian, submission to acceptance · P25–P75 62 days – 117 days
- Acceptance to online
- median 8 days (60 articles)
- Submission to online
- median 102 days
- Sample
- 108 articles with submission and acceptance dates (1,815 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,750 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePublication ethics
- Publication ethics Committee on Publication Ethics
JCEM is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1952
- ISSN
- 0021-972X
- Electronic ISSN
- 1945-7197
- Latest issue on the website
- Volume 111, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
What CAS zone is JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM?
The latest impact factor listed by LetPub is 5.33; CiteScore 11, h-index 491.
How long does peer review take at JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 62–117 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM based?
Of the 113 board members whose country the journal's board page names, 10 (about 9%) are in mainland China; the countries named most often are United States (31), Mainland China (10) and United Kingdom (9). Counted from the institutions listed on the board page; for reference only.
Which databases index JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM?
According to LetPub and DOAJ records, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM is indexed in SCIE and Scopus.
Is JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM open access, and what is the APC?
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM is a hybrid journal. For open-access publication: APC about USD 3,750.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .